F. Hoffmann-La Roche Ltd: Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19

The cobas SARS-CoV-2 Duo test combines the standard qualitative result of a traditional SARS-CoV-2 PCR test with a quantitative result, which measures the viral load of a patient suspected of COVID-19.Potential

Related Keywords

Japan ,United States ,Switzerland ,America ,Nathalie Meetz ,Birgit Masjost ,Loren Kalm ,Thomas Schinecker ,Sabine Borngr ,Gerard Tobin ,Bruno Eschli ,Genentech ,International Standard ,World Health Organization ,Roche Group ,Drug Administration ,Roche Group Media Relations ,Emergency Use Authorization ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Hoffmann ,Oche ,Eceives ,Kobas ,Cars ,First ,Pest ,Psimultaneously ,Etect ,Covid ,Quantitatively ,Measure ,Viral ,Road ,Levels ,